GlassScriptPhysician profile
Michael R Dasu
NPI 1407381130
$1,154.01
in general payments reported to CMS, 2019-2025
14 companies · $52.33 in 2025
The $52.33 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $430 · 2022: $167 · 2023: $286 · 2024: $219 · 2025: $52.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $513.36 | 2021-2023 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Abbott Laboratories | $324.16 | 2022-2025 | Eterna, Proclaim |
| Curonix LLC | $48.62 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $33.67 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $32.91 | 2023-2024 | Orthovisc, Monovisc |
| Integra Lifesciences Corporation | $32.90 | 2023-2024 | Tenoglide |
| Vertex Pharmaceuticals Incorporated | $28.88 | 2024 | |
| Averitas Pharma INC. | $28.38 | 2024 | Qutenza |
| Masimo Corporation | $24.07 | 2024 | Set and Rainbow Set |
| Si-Bone, INC. | $20.36 | 2023 | |
| Collegium Pharmaceutical, INC. | $19.47 | 2023 | Xtampza |
| Nevro Corp. | $18.47 | 2024 | Senza |
| Spinal Simplicity, LLC | $14.42 | 2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $14.34 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dasu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.